Adopting the Evolving Management of HR+/HER2-mBC into Practice cover art

Adopting the Evolving Management of HR+/HER2-mBC into Practice

Adopting the Evolving Management of HR+/HER2-mBC into Practice

By: Annenberg Center for Health Sciences
Listen for free

About this listen

Survival outcomes for patients with HR+/HER2- mBC remain suboptimal, despite first-line treatment strategies with endocrine therapy (ET). Greater understanding of the biology of HR+/HER2- mBC, including the role of biomarkers like ESR1 mutations, and the development of biopsy techniques for early mutation detection, have paved the way for personalized treatment approaches. In this activity, medical oncologists discuss integrating these evidence-based advancements into practice.Annenberg Center for Health Sciences Hygiene & Healthy Living Physical Illness & Disease
activate_mytile_page_redirect_t1
Episodes
  • Therapeutic Approaches for the Treatment of Patients with HR+/HER2- mBC
    Apr 9 2025

    Therapeutic Approaches for the Treatment of Patients with HR+/HER2- mBC

    Show More Show Less
    21 mins
  • Navigating Through the Current Treatment of Patients with HR+/HER2- mBC
    Apr 9 2025

    Navigating Through the Current Treatment of Patients with HR+/HER2- mBC

    Show More Show Less
    7 mins
  • Molecular and Tumor Profiling
    Apr 9 2025

    Molecular and Tumor Profiling

    Show More Show Less
    23 mins

What listeners say about Adopting the Evolving Management of HR+/HER2-mBC into Practice

Average Customer Ratings

Reviews - Please select the tabs below to change the source of reviews.

In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.